As of 2024-12-12, the Intrinsic Value of Biotage AB (BIOT.ST) is
82.96 SEK. This BIOT.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 165.00 SEK, the upside of Biotage AB is
-49.70%.
The range of the Intrinsic Value is 57.68 - 156.01 SEK
82.96 SEK
Intrinsic Value
BIOT.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
57.68 - 156.01 |
82.96 |
-49.7% |
| DCF (Growth 10y) |
77.84 - 202.02 |
109.98 |
-33.3% |
| DCF (EBITDA 5y) |
65.78 - 125.90 |
94.46 |
-42.7% |
| DCF (EBITDA 10y) |
81.22 - 153.78 |
114.33 |
-30.7% |
| Fair Value |
28.97 - 28.97 |
28.97 |
-82.44% |
| P/E |
102.10 - 143.36 |
127.54 |
-22.7% |
| EV/EBITDA |
47.45 - 113.78 |
77.83 |
-52.8% |
| EPV |
53.98 - 72.73 |
63.35 |
-61.6% |
| DDM - Stable |
34.55 - 127.01 |
80.78 |
-51.0% |
| DDM - Multi |
67.91 - 185.70 |
98.48 |
-40.3% |
BIOT.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
13,099.32 |
| Beta |
0.92 |
| Outstanding shares (mil) |
79.39 |
| Enterprise Value (mil) |
12,979.32 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.43% |
| Cost of Debt |
4.25% |
| WACC |
7.35% |